{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-24-000190","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.621559+00:00","generated_at":"2026-05-30T03:29:48.715858+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioRestorative to present Phase 2 BRTX-100 data at spine symposium; Q3 results call Nov 13","bullets":["Additional preliminary 26-52 week blinded data from Phase 2 trial of BRTX-100 for chronic lumbar disc disease to be presented on Nov 13, 2024.","Presentation at Orthopaedic Research Society/Philadelphia Spine Research Society 7th International Spine Research Symposium, Nov 10-14.","Company will host webcasted conference call Nov 13 at 4:30pm ET to review data, Q3 2024 financial results, and provide business update."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-24-000190","json":"https://secwatch.observer/filing/0001021771-24-000190.json","markdown":"https://secwatch.observer/filing/0001021771-24-000190.md","text":"https://secwatch.observer/filing/0001021771-24-000190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000190/0001021771-24-000190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000190/brt8k11624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:29:48.715858+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}